Skip to main content
Caplight Logo









Alithea Biotechnology GmbH

Alithea Biotechnology GmbH

Private
FreiburgHealthcare & Life Scienceshttps://alithea-bio.com/

Last Round

Seed

Jun 23, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Alithea Biotechnology GmbH is a biotechnology company that provides immunopeptidomics research services, AI-driven target discovery, and a proprietary HLA peptide database to support the development of precision immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

immunopeptidomicsHLA peptidecancer immunotherapydrug target validationoff-target toxicityneoantigen detectionTCR therapymass spectrometrycontract researchbiotech SaaSAI drug discoveryin silico safetybioinformatics platformprecision medicinedigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alithea Biotechnology GmbH Comparables

Compare Alithea Biotechnology GmbH with similar companies based on industry and business-model similarity.

Alithea Biotechnology GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pure MHC, LLC
78%
Bruker
71%
ProImmune Ltd
69%

Alithea Biotechnology GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 23, 2026

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 220% MoM, reaching 1.6K.

  • Jun 22, 2026

    Monthly visitors increased 61% MoM.

Recent news

Latest coverage and updates

  • receives_awardJul 21, 2026

    Alithea Bio receives award Tech for Change at VivaTech 2026.

Alithea Biotechnology GmbH Filings

Explore SEC and related filing metadata, where available.

Alithea Biotechnology GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alithea Biotechnology GmbH's valuation, stock price, and market status.

Is Alithea Biotechnology GmbH a public or private company?

Alithea Biotechnology GmbH is a private company.

What is the current stock price of Alithea Biotechnology GmbH?

Alithea Biotechnology GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Alithea Biotechnology GmbH worth (valuation)?

Valuation information for Alithea Biotechnology GmbH is not publicly available.

Can I buy Alithea Biotechnology GmbH stock?

Alithea Biotechnology GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alithea Biotechnology GmbH's last funding round?

Alithea Biotechnology GmbH's most recent funding round was Seed on June 23, 2026.

Who are the main investors in Alithea Biotechnology GmbH?

Investor information for Alithea Biotechnology GmbH is not publicly disclosed.

Will Alithea Biotechnology GmbH IPO soon?

No public IPO plans have been announced for Alithea Biotechnology GmbH.

How can I track Alithea Biotechnology GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alithea Biotechnology GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFreiburg
Employee Range12
Year Founded2019
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?